CEO: Charles M. Baum

Sector: Healthcare
Industry:Biotechnology

Exchange: Nasdaq Global Select

Country: USA

Description: Mirati Therapeutics Inc is a biotechnology company. The company's focuses on precision medicine for oncology therapeutics. The company provides bioavailable inhibitors with distinct target profiles aiming to treat cancer patients.


Key numbers

Market Capitalization:3784278560
Shares Outstanding: 39436000
Float: 38646885.64
Next Earning Date:2020-03-09
TTm EPS: -4.6867
TTm Dividend Rate:
200 days moving average:83.35
50 days moving average: 86.08
One day percent Change: 18.7



2018-06-30, 2018-09-30, 2018-12-31, 2019-03-31,
2018-06-30, 2018-09-30, 2018-12-31, 2019-03-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,